Overview

Dex on Microcirculation in SS-A Double-blinded Study

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The investigators preliminary study showed that dexmedetomidine might improve microcirculation in septic shock patients. To test this effect, the investigators will conduct double-blinded study.
Phase:
Phase 4
Details
Lead Sponsor:
Southeast University, China
Treatments:
Dexmedetomidine